Lisinopril Cost in Minnesota (2026): Prices, Insurance, and Savings

Lisinopril is a generic ACE (angiotensin-converting enzyme) inhibitor, sold under discontinued brand names including Zestril and Prinivil, taken once daily as an oral tablet for hypertension, heart failure, and post-heart-attack survival. In Minnesota, as in every state, generic lisinopril is one of the least expensive prescription drugs on the market. Cash prices, Medicaid rules, and insurance copays are the parts of the picture that shift over time and by pharmacy or plan. The FDA approval, the drug class, and the fact that generic competition exists are the parts that do not.

A note on this page's evidence: pricing figures below reflect general, widely reported ranges for generic lisinopril rather than a Minnesota-specific pricing dataset verified for this article. Anyone using this page to budget for a prescription should confirm the live price at their own pharmacy or through their insurer, since cash and discount-card prices change frequently and vary by location.

The direct answer, and its limits

Generic lisinopril is inexpensive almost everywhere in the United States, including Minnesota, because it has been off patent for decades and multiple manufacturers produce it. For an uninsured patient, retail cash prices for a 30-day supply of a common strength (10 mg or 20 mg) are commonly reported in the single-digit to low-double-digit dollar range at large chain and warehouse pharmacies, with some independent pharmacies pricing higher. Patients with Minnesota Medicaid (Medical Assistance) or commercial insurance generally pay less than the cash price, often $0 to a small flat copay, because lisinopril sits on preferred generic formulary tiers. These are the stable, well-supported parts of the picture. The specific dollar amount you will pay at a specific pharmacy on a specific day is not something a general reference page can state with certainty, because it depends on your plan year, your pharmacy's contracted rate, and any discount card you present.

What is established, what is plausible, and what is not established

Established: Lisinopril is FDA-approved for hypertension, heart failure, and post-myocardial-infarction survival, and it is available as a generic from multiple manufacturers, which is the primary driver of its low cost compared with newer brand-name antihypertensives. It is dosed once daily.

Plausible but requiring local verification: That Minnesota Medicaid and most Minnesota commercial plans place lisinopril on a preferred generic tier with a low copay is consistent with how ACE inhibitors are generally handled by payers nationally, but the specific prior-authorization process, copay amount, and formulary tier for any individual plan can change from year to year and should be confirmed directly with the plan or pharmacy benefit manager rather than assumed from this page.

Not established by anything cited here: Exact current cash prices at named Minnesota pharmacy chains, exact current Medicaid managed-care copay amounts by plan, and claims about how the ACA preventive services mandate applies to lisinopril coverage specifically. These require primary verification (the plan's own formulary document, a live pharmacy price lookup, or a call to the pharmacy) before being treated as fact.

Cash price for uninsured patients

Without insurance, generic lisinopril is one of the cheapest chronic-disease medications available. Large retail chains and warehouse pharmacies frequently include lisinopril in low, flat-price generic drug programs, and independent pharmacies vary more widely. Because pricing changes by location, by pharmacy, and over time, the only reliable way to know your price is to call the pharmacy or check a live pharmacy-price tool the same week you plan to fill the prescription. Dose strength (for example, 10 mg versus 40 mg) usually makes little difference to the cash price of a tablet at most pharmacies, since manufacturing cost is not the main driver of retail pricing for a decades-old generic.

Minnesota Medicaid (Medical Assistance) coverage

Minnesota's Medicaid program, Medical Assistance, covers lisinopril, and a prior authorization requirement has been reported for the drug. Lisinopril is a first-line antihypertensive option under national hypertension guidelines, which is one reason ACE inhibitors like lisinopril remain broadly available on state Medicaid formularies. That guideline-level support does not by itself guarantee any specific Minnesota managed-care plan's copay or PA turnaround time. Minnesota Medicaid managed care is administered through several plans, and formulary placement, PA requirements, and copay amounts can differ between them and can change between plan years. If a specific copay or approval timeline matters for a patient's budgeting, it should be confirmed with the plan directly or through the prescriber's office, not assumed from a general reference page.

MinnesotaCare, the state's subsidized coverage option, is reported to also cover lisinopril on a preferred generic tier, subject to the same caveat about year-to-year verification.

Verification checklist: stable facts versus facts you must check today

Use this checklist to separate what you can trust from a reference page versus what you must verify at the point of care, because pricing and coverage pages (including this one) go stale quickly while clinical and regulatory facts do not.

Stable facts (federal, clinical, rarely change; safe to rely on from a reference page):

• Lisinopril's FDA-approved indications are hypertension, heart failure, and improving survival after acute myocardial infarction.
• Lisinopril is an ACE inhibitor, dosed once daily as an oral tablet.
• Lisinopril has been available generically for years, which structurally keeps its price low relative to brand-only antihypertensives.
• Compounding of a patient-specific lisinopril preparation by a state-licensed 503A pharmacy is a legal pathway under federal law when a valid prescription exists.
• Tablet splitting of a scored tablet is an FDA-acknowledged practice for some medications, though it should only be done for a specific medication if a pharmacist or prescriber confirms it is appropriate for that formulation and dose.

Date-sensitive facts (verify before you rely on them, ideally the same week you fill or renew coverage):

• The exact cash price at a specific Minnesota pharmacy this month.
• Whether your specific Minnesota Medicaid managed-care plan currently requires prior authorization, and the current turnaround time.
• Your specific commercial plan's current formulary tier and copay for lisinopril, since formularies are typically revised annually.
• Whether a discount card price or your insurance copay is lower right now, since discount card negotiated rates change without notice.
• Whether a given compounding pharmacy in your area currently stocks a lisinopril suspension or custom strength, and whether your insurance will reimburse a compounded product.
• Current telehealth prescribing rules in Minnesota, since state medical board policy on telehealth has evolved since the COVID-19 pandemic and can change again.

Commercial insurance

Commercial insurers operating in Minnesota generally place generic lisinopril on their lowest cost-sharing generic tier, consistent with how ACE inhibitors are typically handled nationally because they are inexpensive, first-line, and guideline-supported. Typical copays for a low generic tier are commonly reported as low, sometimes zero, but the specific amount for any plan depends on that plan's benefit design for the current year and should be confirmed through the insurer's member portal or by calling member services. Patients on a high-deductible health plan may pay the full cash price until the deductible is met; even then, generic lisinopril's cash price is usually far lower than the deductible-phase price of a brand-name drug. A 90-day mail-order fill through a plan's pharmacy benefit manager is commonly cheaper per month than three separate 30-day retail fills, though the exact saving depends on the plan.

Discount programs and lower-cost pharmacy options

Free prescription discount programs (the kind that generate a coupon code or card at checkout) commonly list generic lisinopril at low prices at major chain pharmacies, and warehouse pharmacies and $4-generic programs at some large retailers have historically included lisinopril. Because these prices and program terms change without notice, confirm the current price the same day you plan to fill, either through the program's own lookup tool or by asking the pharmacist to check both your insurance price and the discount price. A discount card cannot legally be combined with insurance billing for the same fill; the pharmacist applies whichever price is lower.

Community health centers that operate 340B pharmacies, present in the Twin Cities and other Minnesota population centers, may offer reduced pricing for eligible patients. Eligibility rules vary by site and should be confirmed directly with the health center.

Compounded lisinopril: legality and when it is used

Compounded lisinopril, most often a liquid suspension, is legal in Minnesota when prepared by a state-licensed 503A compounding pharmacy against a valid prescription for an individual patient. This pathway exists under Section 503A of the Federal Food, Drug, and Cosmetic Act, which is distinct from 503B outsourcing facilities that produce larger batches for offices or hospitals rather than individual patients. Compounded lisinopril is typically used for patients who cannot swallow tablets, such as some pediatric patients or adults with dysphagia, rather than as a cost-saving substitute for the commercially manufactured tablet. Pricing for a compounded suspension varies by pharmacy and is often higher than the standard generic tablet; insurance coverage for compounded products is inconsistent and should be confirmed before filling.

Getting lisinopril through telehealth

Telehealth prescribing of medications for chronic conditions like hypertension is broadly permitted when a licensed provider conducts an evaluation that meets the applicable standard of care, and hypertension management is one of the conditions considered reasonably suited to telehealth because blood pressure can be monitored at home with a validated cuff. State rules on what counts as an adequate telehealth evaluation, and whether an in-person visit is ever required, are set by the state medical board and can change; current Minnesota-specific requirements should be confirmed directly with the Minnesota Board of Medical Practice or with the telehealth platform's compliance information rather than assumed. A typical telehealth visit for ongoing hypertension management, plus a lisinopril fill, will usually cost less in total for an insured patient than for a cash-pay patient, but exact totals depend on the visit fee and the pharmacy price on the day of the fill.

Lisinopril compared with other ACE inhibitors and ARBs

Lisinopril is generally reported as one of the least expensive ACE inhibitors available, with other generic ACE inhibitors such as enalapril, benazepril, and ramipril commonly priced somewhat higher per month, though exact multiples should not be treated as fixed since generic pricing fluctuates. The cost gap between ACE inhibitors and generic angiotensin receptor blockers (ARBs) such as losartan has narrowed as more ARBs have gone generic; losartan is now frequently priced close to lisinopril. Large randomized trials have compared ACE inhibitors and ARBs and reported broadly similar cardiovascular outcomes for many patients, which supports treating the choice between the two classes as largely a matter of tolerability, kidney function, and cost rather than a fixed clinical hierarchy; the specific trial data behind this comparison should be checked against the primary literature before being cited as a precise statistic. For a patient with uncomplicated hypertension and no specific reason to prefer one class, a small monthly price difference is a reasonable, though not the only, factor in choosing between an ACE inhibitor and an ARB, and that decision should be made with a prescriber who knows the patient's kidney function, potassium levels, and other medications.

Practical ways to lower the price

A 90-day fill is usually cheaper per month than three 30-day fills, whether through insurance mail order or a direct-to-consumer pharmacy. Confirming that the pharmacy is dispensing the generic rather than accidentally billing a brand-name product takes a moment and avoids a large unexpected charge, since Minnesota law permits automatic generic substitution unless a prescriber specifically writes "dispense as written." Tablet splitting of a scored lisinopril tablet is a practice sometimes addressed in general pharmacy guidance, but whether it is appropriate for a specific patient's tablet and dose is a question for a pharmacist or prescriber, not a do-it-yourself cost-saving decision, and it will rarely produce meaningful savings given how low generic lisinopril pricing already is. Patients without insurance, Medicaid eligibility, or access to a discount program can call 211, Minnesota's health and human services referral line, to be connected with local low-cost pharmacy resources.

Safety context that matters more than price

Cost should never be the only factor in a hypertension treatment decision. Lisinopril and other ACE inhibitors are contraindicated in pregnancy because of fetal risk, and patients should tell a prescriber immediately if they are or may become pregnant. ACE inhibitors can raise potassium levels and affect kidney function, which is why prescribers typically check labs such as serum creatinine and potassium before starting the drug and periodically afterward. Angioedema, a rare but serious swelling reaction that can affect the face, lips, tongue, or throat, is a recognized risk with ACE inhibitors and is a medical emergency: anyone who develops sudden swelling or difficulty breathing or swallowing while on lisinopril should seek emergency care immediately and should not simply switch to a cheaper alternative on their own. A persistent dry cough is a known, non-emergency side effect that sometimes leads patients and prescribers to switch to an ARB.

Frequently asked questions

References

1. U.S. Food and Drug Administration. Lisinopril approved drug product and labeling information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
2. U.S. Preventive Services Task Force. Screening for hypertension in adults: recommendation statement. https://www.uspstf.org/recommendation/high-blood-pressure-in-adults-screening

Pricing, coverage, and program details in this article reflect general, commonly reported ranges as of 2026 and are not a substitute for a live pharmacy quote or a plan's current formulary. Trial-level claims about ACE inhibitor versus ARB outcomes are described generally pending verification against the primary published literature.